What's New

Last Posted: Jan 26, 2023

• Relative Risk of Bladder and Kidney Cancer in Lynch Syndrome: Systematic Review and Meta-Analysis.
  Nassour Anthony-Joe et al. Cancers 2023 15(2)
• Machine learning approach for prediction of pT3a upstaging and outcomes of localized RCC (UroCCR-15).
  Boulenger de Hauteclocque A et al. BJU international 2023
• Adoption of Innovative Therapies Across Oncology Practices-Evidence From Immunotherapy.
  Carroll Caitlin E et al. JAMA oncology 2023
• Bone metastasis risk and prognosis assessment models for kidney cancer based on machine learning.
  Ji Lichen et al. Frontiers in public health 2022 101015952
• Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases.
  Zeng Chenjie et al. JAMA oncology 2022
• The blood metabolome of incident kidney cancer: A case–control study nested within the MetKid consortium
  F Guida et al, PLOS Medicine, September 21, 2021
• Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
  Bratslavsky Gennady et al. Cancer 2021
• Application of the ACMG/NSGC genetic referral guidelines for hereditary renal cell carcinoma at the University of Miami, from 2014 to 2017.
  Leuchter Jessica D et al. American journal of medical genetics. Part A 2021
• Deep learning for end-to-end kidney cancer diagnosis on multi-phase abdominal computed tomography
  KH Uhm et al, NPJ Precision Oncology, June 18, 2021
• Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum.
  Zhou Jingan et al. Annals of surgical oncology 2021
• Acceptability and potential impact on uptake of using different risk stratification approaches to determine eligibility for screening: A population-based survey.
  Usher-Smith Juliet A et al. Health expectations : an international journal of public participation in health care and health policy 2020 Dec
• LINC02738 Participates in the Development of Kidney Cancer Through the miR-20b/Sox4 Axis.
  Han Chao et al. OncoTargets and therapy 2020 1310185-10196
• Renal Manifestations of Tuberous Sclerosis Complex.
  Nair Nikhil et al. Journal of kidney cancer and VHL 2020 7(3) 5-19
• Clinical predictors of a positive test result in patients undergoing genetic evaluation for a hereditary kidney cancer syndrome.
  Kokorovic Andrea et al. Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2020 Mar
• Genetic Testing in Kidney Cancer Patients: Who, When, and How?
  Lui Sandy T et al. European urology focus 2019 Oct
• Resistance to Immune Checkpoint Blocker May Be Linked to Metabolic Imbalance
  ASCO Post, October 10, 2019
• Family Members at Higher Risk for Blood Cancers
  P Harrison, Medscape, September 9, 2019
• Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review.
  Lommen Kim et al. European urology oncology 2019 Aug
• FDA Approvals Provide Advances for a Range of Cancer Types
  K Honey, AACR Blogs, August 6, 2019
• Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database.
  Kushnir I et al. Clinical oncology (Royal College of Radiologists (Great Britain)) 2019 Aug

More